User profiles for Helena Winstone

Helena Winstone

PDRA, King's College London
Verified email at kcl.ac.uk
Cited by 2178

[HTML][HTML] Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

…, G Betancor, HD Wilson, AW Signell, H Winstone… - Nature …, 2020 - nature.com
Antibody responses to SARS-CoV-2 can be detected in most infected individuals 10–15 d
after the onset of COVID-19 symptoms. However, due to the recent emergence of SARS-CoV-…

[HTML][HTML] Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern

…, MJ Lista, AM Ortega-Prieto, H Wilson, H Winstone… - Nature …, 2021 - nature.com
COVID-19 vaccine design and vaccination rollout need to take into account a detailed
understanding of antibody durability and cross-neutralizing potential against SARS-CoV-2 and …

The polybasic cleavage site in SARS-CoV-2 spike modulates viral sensitivity to type I interferon and IFITM2

H Winstone, MJ Lista, AC Reid, C Bouton… - Journal of …, 2021 - Am Soc Microbiol
The cellular entry of severe acute respiratory syndrome-associated coronaviruses types 1
and 2 (SARS-CoV-1 and -2) requires sequential protease processing of the viral spike …

The P681H mutation in the spike glycoprotein of the alpha variant of SARS-CoV-2 escapes IFITM restriction and is necessary for type I interferon resistance

MJ Lista, H Winstone, HD Wilson, A Dyer… - Journal of …, 2022 - Am Soc Microbiol
… Graham C, Seow J, Huettner I, Khan H, Kouphou N, Acors S, Winstone H, Pickering … Helena
Winstone … Maria Jose Lista and Helena Winstone contributed equally to this work. The order …

[PDF][PDF] Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B. 1.1. 7 variant

…, I Huettner, H Khan, N Kouphou, S Acors, H Winstone… - Immunity, 2021 - cell.com
Interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the receptor
ACE2 on host cells is essential for viral entry. RBD is the dominant target for neutralizing …

[HTML][HTML] Impact of the B. 1.1. 7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike

…, I Huettner, H Khan, N Kouphou, S Acors, H Winstone… - bioRxiv, 2021 - ncbi.nlm.nih.gov
The interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the ACE2
receptor on host cells is essential for viral entry. RBD is the dominant target for neutralizing …

[PDF][PDF] TLR4-mediated pathway triggers interferon-independent G0 arrest and antiviral SAMHD1 activity in macrophages

P Mlcochova, H Winstone, L Zuliani-Alvarez, RK Gupta - Cell reports, 2020 - cell.com
Macrophages exist predominantly in two distinct states, G0 and a G1-like state that is accompanied
by phosphorylation of SAMHD1 at T592. Here, we demonstrate that Toll-like receptor …

[HTML][HTML] TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction

H Khan, H Winstone, JM Jimenez-Guardeño… - Plos …, 2021 - journals.plos.org
Interferons play a critical role in regulating host immune responses to SARS-CoV-2, but the
interferon (IFN)-stimulated gene (ISG) effectors that inhibit SARS-CoV-2 are not well …

The P681H mutation in the Spike glycoprotein confers Type I interferon resistance in the SARS-CoV-2 alpha (B. 1.1. 7) variant

MJ Lista, H Winstone, HD Wilson, A Dyer, S Pickering… - BioRxiv, 2021 - biorxiv.org
Variants of concern (VOCs) of severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2)
threaten the global response to the COVID-19 pandemic. The alpha (B.1.1.7) variant …

[HTML][HTML] Antibody longevity and cross-neutralizing activity following SARS-CoV-2 wave 1 and B. 1.1. 7 infections

…, S Pickering, AM Ortega-Prieto, H Wilson, H Winstone… - MedRxiv, 2021 - ncbi.nlm.nih.gov
As SARS-CoV-2 variants continue to emerge globally, a major challenge for COVID-19
vaccination is the generation of a durable antibody response with cross-neutralizing activity …